Top 10 Railroad Companies To Own For 2015

Top 10 Railroad Companies To Own For 2015: Lexicon Pharmaceuticals Inc.(LXRX)

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of various human diseases. The company utilizes gene knockout technologies and an integrated platform of medical technologies to systematically study the physiological and behavioral functions of approximately 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. Its portfolio of orally-delivered small molecule compounds that have completed or are presently conducting phase 2 clinical trails includes LX4211 for the treatment of type 2 diabetes; LX1031 for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX1032 for the treatment of the symptoms associated with carcinoid syndrome; and LX2931 for the treatment of rheumatoid arthritis and other autoimmune diseases. The company also develops LX1033, an orally-delivered small molecule compound that is in phase 1 clinical trails for the treatment of irritable bowel syndrome and other gastrointestinal disorders. In addition, it develops three orally-delivered small molecule compounds in preclinical development stage that include LX7101 for treatment of glaucoma; LX5061 for the treatment of osteoporosis; and LX2311 for the treatment of autoimmune diseases. Further, the company has small molecule compounds from various additional drug discovery programs in various stages of preclinical research. It has drug discovery and development collaborations with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. The company also has a series of agreements with Symphony Icon, Inc. for the financing of clinical development programs; and an alliance with Nuevolution A/S to access Nuevolution?s Chemetics chemistry tec! hnology. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.

Advisors' Opinion:

• [By Garrett Cook]

  Lexicon Pharmaceuticals (NASDAQ: LXRX) shares were also up, gaining 6.05 percent to $1.66. Lexicon and JDRF have collaborated for Phase 2 clinical trial of LX4211 in Type 1 Diabetes.

• [By Garrett Cook]

  Lexicon Pharmaceuticals (NASDAQ: LXRX) shares were also up, gaining 3.18 percent to $1.62. Lexicon and JDRF have collaborated for Phase 2 clinical trial of LX4211 in Type 1 Diabetes.

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Tuesday’s session are OncoMed Pharmaceuticals Inc.(OMED), Lexicon Pharmaceuticals Inc.(LXRX) and Krispy Kreme Doughnuts Inc.(KKD)

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-railroad-companies-to-own-for-2015-3.html